Medicenna Therapeutics Corp.
MDNAF
$1.15
$0.054.55%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.16% | 10.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.26% | -0.08% | |||
| Operating Income | 0.26% | 0.08% | |||
| Income Before Tax | 0.46% | -530.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.46% | -530.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.46% | -530.64% | |||
| EBIT | 0.26% | 0.08% | |||
| EBITDA | 0.06% | 0.32% | |||
| EPS Basic | 1.62% | -507.55% | |||
| Normalized Basic EPS | 1.48% | -509.09% | |||
| EPS Diluted | 1.62% | -507.55% | |||
| Normalized Diluted EPS | 1.48% | -509.09% | |||
| Average Basic Shares Outstanding | 1.07% | 5.55% | |||
| Average Diluted Shares Outstanding | 1.07% | 5.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||